Plus Therapeutics Inc. (PSTV)
Plus Therapeutics Statistics
Share Statistics
Plus Therapeutics has 17M shares outstanding. The number of shares has increased by 106.6% in one year.
| Shares Outstanding | 17M |
| Shares Change (YoY) | 106.6% |
| Shares Change (QoQ) | 99.87% |
| Owned by Institutions (%) | 0.39% |
| Shares Floating | 16.57M |
| Failed to Deliver (FTD) Shares | 109.25K |
| FTD / Avg. Volume | 0.68% |
Short Selling Information
The latest short interest is 52.34K, so 0.89% of the outstanding shares have been sold short.
| Short Interest | 52.34K |
| Short % of Shares Out | 0.89% |
| Short % of Float | 0.91% |
| Short Ratio (days to cover) | 0.98 |
Valuation Ratios
The PE ratio is -5.88 and the forward PE ratio is -0.57. Plus Therapeutics's PEG ratio is 0.06.
| PE Ratio | -5.88 |
| Forward PE | -0.57 |
| PS Ratio | 0 |
| Forward PS | 0.1 |
| PB Ratio | -8.53 |
| P/FCF Ratio | -7.14 |
| PEG Ratio | 0.06 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Plus Therapeutics.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.34, with a Debt / Equity ratio of -0.38.
| Current Ratio | 0.34 |
| Quick Ratio | 0.34 |
| Debt / Equity | -0.38 |
| Debt / EBITDA | - |
| Debt / FCF | -0.31 |
| Interest Coverage | 0 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $0 |
| Profits Per Employee | $-648.9K |
| Employee Count | 20 |
| Asset Turnover | 0 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | 0 |
| Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by -58.82% in the last 52 weeks. The beta is 0.67, so Plus Therapeutics's price volatility has been higher than the market average.
| Beta | 0.67 |
| 52-Week Price Change | -58.82% |
| 50-Day Moving Average | 1.04 |
| 200-Day Moving Average | 1.31 |
| Relative Strength Index (RSI) | 44.52 |
| Average Volume (20 Days) | 16.14M |
Income Statement
| Revenue | n/a |
| Gross Profit | 0 |
| Operating Income | 0 |
| Net Income | -12.98M |
| EBITDA | 0 |
| EBIT | n/a |
| Earnings Per Share (EPS) | -0.2 |
Balance Sheet
The company has 76K in cash and 3.37M in debt, giving a net cash position of -3.29M.
| Cash & Cash Equivalents | 76K |
| Total Debt | 3.37M |
| Net Cash | -3.29M |
| Retained Earnings | -493.48M |
| Total Assets | 6.63M |
| Working Capital | -10.29M |
Cash Flow
In the last 12 months, operating cash flow was -10.55M and capital expenditures -146K, giving a free cash flow of -10.7M.
| Operating Cash Flow | -10.55M |
| Capital Expenditures | -146K |
| Free Cash Flow | -10.7M |
| FCF Per Share | -0.16 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
PSTV does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Analyst Forecast
The average price target for PSTV is $9, which is 1068.8% higher than the current price. The consensus rating is "Buy".
| Price Target | $9 |
| Price Target Difference | 1068.8% |
| Analyst Consensus | Buy |
| Analyst Count | 3 |
Stock Splits
The last stock split was on May 1, 2023. It was a backward split with a ratio of 1:15.
| Last Split Date | May 1, 2023 |
| Split Type | backward |
| Split Ratio | 1:15 |
Scores
| Altman Z-Score | -111.4 |
| Piotroski F-Score | 3 |